Cargando…
Cortisol and DHEAS in COVID-19
Autores principales: | Yavropoulou, Maria P., Sfikakis, Petros P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660206/ https://www.ncbi.nlm.nih.gov/pubmed/36374475 http://dx.doi.org/10.1007/s42000-022-00417-3 |
Ejemplares similares
-
Assessment of DHEAS, cortisol, and DHEAS/cortisol ratio in patients with COVID-19: a pilot study
por: Tomo, Sojit, et al.
Publicado: (2022) -
Time-dependence of dehydroepiandrosterone (DHEA), dehydroepiandrosterone-sulfate (DHEAS), and cortisol in survivors and non-survivors of severe sepsis
por: Marx, C, et al.
Publicado: (2002) -
Alterations in cortisol and interleukin-6 secretion in patients with COVID-19 suggestive of neuroendocrine-immune adaptations
por: Yavropoulou, Maria P., et al.
Publicado: (2022) -
Salivary cortisol, dehydroepiandrosteronesulphate (DHEA–S) and testosterone in women with chronic migraine
por: Patacchioli, F. R., et al.
Publicado: (2006) -
Cortisol and DHEA-S levels in pregnant women with severe anxiety
por: Leff-Gelman, Philippe, et al.
Publicado: (2020)